Papers by Ajay Kshirsagar
Silymarin, a flavonolignan from the seeds of 'milk thistle' (Silybum marianum), has been ... more Silymarin, a flavonolignan from the seeds of 'milk thistle' (Silybum marianum), has been widely used from ancient times because of its excellent hepatoprotective action. It is a mixture of mainly three flavonolignans, viz, silybin, silidianin and silychristine, with silybin being the most active. Silymarin has been used medicinally to treat liver disorders, including acute and chronic viral hepatitis, toxin/drug-induced hepatitis and cirrhosis and alcoholic liver diseases. It has also been reported to be effective in certain cancers. Its mechanism of action includes inhibition of hepatotoxin binding to receptor sites on the hepatocyte membrane; reduction of glutathione oxidation to enhance its level in the liver and intestine; antioxidant activity and stimulation of ribosomal RNA polymerase and subsequent protein synthesis, leading to enhanced hepatocyte regeneration. It is orally absorbed but has very poor bioavailability due to its poor water solubility. This review focuse...
Bookmarks Related papers MentionsView impact
IRJP, 2019
The 2, 3-Benzoquinoline derivatives have been synthesized by condensation of dimedone, aldehydes ... more The 2, 3-Benzoquinoline derivatives have been synthesized by condensation of dimedone, aldehydes and aniline through conventional methods. Their chemical structures were identified by spectral analysis like FT-IR, 1H-NMR, and Mass spectrum. All the synthesized compounds of 2, 3-Benzoquinoline derivatives were screened for their possible anti-inflammatory and anticancer activity. In the present investigation test compounds R1, R2, and R3 were evaluated for in-vitro anti-inflammatory activity and in-vivo anticancer activity to provide the possible link between Inflammation and Inflammation Induced cancer. The results have clearly demonstrated that the compounds R1, R2, and R3 at different concentrations have good anti-protein denaturation activity; however it exhibited prominent anti-protein denaturation activity at its lowest concentration. The IC50 values of R1, R2, and R3 of the synthetic test compounds were found to be 115μg/ml, 99μg/ml, and 96μg/ml against MCF-7 cell. The study a...
Bookmarks Related papers MentionsView impact
Pharmacognosy Reviews, 2009
Bookmarks Related papers MentionsView impact
Journal of Ethnopharmacology, 2015
Areca catechu Linn. (Arecaceae) nut is a popular folk remedy for the treatment of migraine in Ker... more Areca catechu Linn. (Arecaceae) nut is a popular folk remedy for the treatment of migraine in Kerala and Tamil Nadu states of India. This study was designed to investigate the effect of hydroalcoholic extract of A. catechu L. nut (ANE) treatment on migraine pain in rat models to strengthen its use as an anti-migraine therapy. Bradykinin (0.1 μmol/kg) injection in to left femoral vein of rat produced PPE which was measured with luminescence spectrometer. Vocalizations were produced in rats with 10 μg of bradykinin infusion into common carotid artery. Phonogram was recorded before, during and for 5min after bradykinin injection and sumatriptan was used as a standard anti-migraine drug. In both models, the ANE was orally administered at doses of 250 and 500 mg/kg, 60 min before bradykinin infusion. The PPE was reduced in both ANE treated groups of rats. The percent fluorescein was significantly increased in positive control group (97.00±1.7%; p<0.0001) compared to negative control (63.87±1.2%). With ANE treatments (250 and 500 mg/kg) PPE was significantly decreased to 88.88±1.4% (p<0.01) and 83.55±0.1% (p<0.0001) compared to positive control group, respectively. On the other hand in the model of vocalization, with 250 and 500 mg/kg ANE treatment, vocalization was significantly reduced to 33.33% and 16.66%, respectively, compared to saline treated rats. The reduction in vocalization is comparable to the reference drug sumatriptan. The findings provide the strong evidence for anti-migraine potential of ANE in rat models of migraine. In summary, therapeutic intervention with ANE treatment could be a promising strategy for prevention of migraine.
Bookmarks Related papers MentionsView impact
Journal of Complementary and Integrative Medicine, 2000
Ethanol extract of Calotropis gigantea flowers (CGFE) was evaluated for its antioxidant and hepat... more Ethanol extract of Calotropis gigantea flowers (CGFE) was evaluated for its antioxidant and hepatoprotective activity to validate its use in traditional therapeutic indications. This CGFE exhibited significant antioxidant activity (at 20, 40, 60, 80 and 100 µg/ml in vitro) as evidenced by its hydroxyl, nitric oxide and hydrogen peroxide anion radical scavenging activities. This in vitro antioxidant activity was reinforced by a significant hepatoprotection (at 250 and 500 mg/kg dose) by decreasing the activity of serum glutamate oxaloacetate transaminase and serum glutamate pyruvate transaminase. The hepatoprotective activity of the CGFE was comparable with standard drug silymarin (100 mg/kg, p.o.).The results obtained from present study indicate the presence of natural antioxidants and hepatoprotective constituents. Hence, the above finding confirms in vitro antioxidant and hepatoprotective potential of CGFE in mice.
Bookmarks Related papers MentionsView impact
Acute and subacute toxicity of the ethanolic extract from Calotropis gigantea R.Br. flower was in... more Acute and subacute toxicity of the ethanolic extract from Calotropis gigantea R.Br. flower was investigated. In acute toxicity study oral dose of 2000 mg/kg of the ethanolic extract did not produce mortality or changes in the general behavior and gross appearance of internal organs of mice and rats. In subacute toxicity study, ethanolic extract was evaluated at 250, 500 or 1000 mg/kg/day, orally for 30 days in rats. The behavioral response profile of the treated mice and rat was also evaluated along with other parameters such as, absolute and relative body weight along with relative weight of various organs. Biochemical and hematological parameters were analyzed in order to study the time-dependent effect and correlation of the extract. All treated animals did not show any signs of toxicity during the experimental period. There were no significant differences in the body and organ weights between the control and the treated group of mice and rats. Hematological (WBC, RBC, HGB, HCT, ...
Bookmarks Related papers MentionsView impact
Bookmarks Related papers MentionsView impact
International Journal of Inflammation, 2014
Aloe emodin is isolated compound of aloe vera which is used traditionally as an anti-inflammatory... more Aloe emodin is isolated compound of aloe vera which is used traditionally as an anti-inflammatory agent. In vitro pharmacokinetic data suggest that glucuronosyl or sulfated forms of aloe emodin may provide some limitations in its absorption capacity. Aloe emodin was reported to have in vitro anti-inflammatory activity due to inhibition of inducible nitric oxide (iNO) and prostaglandin E2, via its action on murine macrophages. However, present work evidenced that molecular docking of aloe emodin modulates the anti-inflammatory activity, as well as expression of COX-2 (cyclooxygenase-2) in rodent. The AEC (4,5-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2 carboxylic acid) was synthesized using aloe emodin as starting material. The study was planned for evaluation of possible anti-inflammatory and antiarthritic activity in carrageenan rat induced paw oedema and complete Freund's adjuvant induced arthritis in rats. The AE (aloe emodin) and AEC significantly (P < 0.001) reduced carrageenan induced paw edema at 50 and 75 mg/kg. Complete Freund's adjuvant induced arthritis model showed significant (P < 0.001) decrease in injected and noninjected paw volume, arthritic score. AE and AEC showed significant effect on various biochemical, antioxidant, and hematological parameters. Diclofenac sodium 10 mg/kg showed significant (P < 0.001) inhibition in inflammation and arthritis.
Bookmarks Related papers MentionsView impact
Pharmacology Biochemistry and Behavior, 2012
Comparative neuroprotective potential of silymarin, piracetam and protocatechuic acid ethyl ester... more Comparative neuroprotective potential of silymarin, piracetam and protocatechuic acid ethyl ester (PCA) was evaluated in focal ischemic rats. Various pharmacological, biochemical (lipid peroxidation, reduced glutathione, catalase, nitrite content, brain water content) and behavioural (memory impairment, motor control, neurological score) including infarct size and histopathological alterations were evaluated. Silymarin (200mg/kg) and PCA treatment significantly improved behavioural, biochemical and histopathological changes, and reduced water content and infarct size. However, piracetam only improved behavioural and histopathological changes, reduced water content and infarct size. The findings indicate that silymarin exhibits neuroprotective activity better than PCA and piracetam in focal ischemia/reperfusion reflected by its better restoration of behavioural and antioxidant profile.
Bookmarks Related papers MentionsView impact
Pharmacognosy Reviews, 2010
Hygrophila spinosa T Ander, belonging to the family Acanthaceae, is a promising medicinal plant w... more Hygrophila spinosa T Ander, belonging to the family Acanthaceae, is a promising medicinal plant with great economic potential. The medicinal value of H. spinosa has been appreciated in the ancient medical literature. The plant contains terpenoids, alkaloids, flavonoids, and is traditionally known as an aphrodisiac, renal tonic, and for its health-promoting properties. The plant is cultivated throughout India. However, systematic information on the different aspects of this species is not available. In this review, an attempt has been made to present this information.
Bookmarks Related papers MentionsView impact
Journal of Ethnopharmacology, 2011
Bookmarks Related papers MentionsView impact
Journal of Complementary and Integrative Medicine, 2000
Diabetic neuropathic pain, an important microvascular complication in diabetes, is recognised as ... more Diabetic neuropathic pain, an important microvascular complication in diabetes, is recognised as one of the most difficult types of pain to treat. The development of tolerance, inadequate relief, and potential toxicity of classical antinociceptives warrant the investigation of the newer agents to relieve this pain. Reactive oxygen/nitrogen species, increased oxidative stress, cytokines, and apoptosis are implicated in the pathogenesis of diabetic neuropathy. The aim of the present study was to explore the effect of methanolic extract of aerial parts of H. spinosa (HSME) on alloxan induced diabetic neuropathy in Wistar rats. Diabetic rats developed neuropathy after the third week of diabetes induction. Chronic treatment with HSME (250, 500, and 750 mg/kg body weight; p.o.) for 6 weeks starting from the 3rd week of alloxan injection showed significant increase in the pain threshold levels as compared to diabetic rats. HSME treated diabetic animals showed significant decrease in blood glucose level and increase in body weight as compared to diabetic control animals. The changes in lipid peroxidation status and antioxidant enzymes levels observed in sciatic nerve of diabetic rats were significantly restored by HSME treatment. Thus, the results suggest therapeutic potential of H. spinosa in treatment of diabetic neuropathy.
Bookmarks Related papers MentionsView impact
Inflammopharmacology, 2011
Anti-inflammatory and analgesic activity of protocatechuic acid (PCA), a natural product, was eva... more Anti-inflammatory and analgesic activity of protocatechuic acid (PCA), a natural product, was evaluated in different rat models (viz., carrageenan-induced paw oedema, cotton pellet-induced granuloma and Freund's adjuvant arthritis) of inflammation and chemical and heat induced mouse models of pain. Treatment with PCA inhibited significantly different biological parameters like hind paw oedema, granuloma exudates formation and arthritis index in carrageenan oedema, cotton pellet granuloma and Freund's adjuvant arthritis, respectively. The biochemical changes viz., glutathione, superoxide dismutase, catalase, lipid peroxidation and NO in oedematous or in liver tissues and serum alanine aminotransferase and lactic dehydrogenase occurred during different types of inflammation were either significantly restored or inhibited with PCA pretreatment. Present experimental findings demonstrate promising anti-inflammatory and analgesic activity of PCA which is comparable with that of standard drugs used.
Bookmarks Related papers MentionsView impact
Food and Chemical Toxicology, 2010
The hydroalcoholic extract of Areca catechu L. (ANE) nut was screened for its analgesic, anti-inf... more The hydroalcoholic extract of Areca catechu L. (ANE) nut was screened for its analgesic, anti-inflammatory and in vitro antioxidant potential. Three doses of ANE (250, 500 and 1000 mg/kg orally) were tested for analgesic and anti-inflammatory activities. Evaluation of analgesic activity of ANE was performed using hot plate and formalin test in mice. ANE showed maximum increase in hot plate reaction time (56.27%, p<0.01), while reduced the duration of licking/biting behaviors in first (39.45%, p<0.05) and second (92.71%, p<0.01) phases of the formalin test indicating significant analgesic activity. ANE reduced the paw edema considerably (86.79% inhibition after 24h, p<0.01) in dose-dependent manner compared to carrageenan-induced rat. In addition, in vitro antioxidant activity of ANE was investigated by total phenolic content (TPC) and hydrogen peroxide assay. The IC(50) observed in hydrogen peroxide assay was 83.14 μg/ml and TPC 120.56±21.09 mg QE/g. Altogether, these results suggest that the hydroalcoholic extract of Areca catechu could be considered as a potential analgesic, anti-inflammatory and antioxidant agent.
Bookmarks Related papers MentionsView impact
Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2011
The dipeptidyl peptidase IV (DPP IV) enzyme is a novel target for the treatment of type 2 diabete... more The dipeptidyl peptidase IV (DPP IV) enzyme is a novel target for the treatment of type 2 diabetes. Several DPP IV inhibitors are in the clinical development, since they are safe and tolerable with no increased risk of adverse events compared to placebo and have a low risk of hypoglycemia. They are flourishing as monotherapy and also in combination with commonly prescribed antidiabetic agents and are appropriate for once-daily oral dosing. However, further studies are needed to validate both long-term β-cell preservation and the role of these agents in the management of diabetes. The present review gives an inside out of the DPP IV inhibitors for its success, failure and future prospects in the treatment of diabetes and associated complication.
Bookmarks Related papers MentionsView impact
ijprd.com
... 11 IN VIVO AND IN VITRO SCREENING OF ANTIMIGRAINE DRUG: STUDIES IN ANIMAL MODEL OF MIGRAINE A... more ... 11 IN VIVO AND IN VITRO SCREENING OF ANTIMIGRAINE DRUG: STUDIES IN ANIMAL MODEL OF MIGRAINE Amol Bhandare1*, Neeraj Vyawahare1, Ajay Kshirsagar1,2, Imtiyaz Ansari1, Sagar Shinde1, Bharat Zope1 ... INTRODUCTION Amol Bhandare Page 2. ...
Bookmarks Related papers MentionsView impact
ABSTRACT Orphan/rare disorders is the name given to the diseases of varied etiology with low prev... more ABSTRACT Orphan/rare disorders is the name given to the diseases of varied etiology with low prevalence rate and for the majority of which there is no treatment available while ‘Orphan drugs' is the term given to those drugs, intended for the treatment of rare disorders. The number of patients affected is so small that it is not profitable to invest in research and development or to market them. Orphan diseases are often so rare that a physician may observe only one case a year or less. According to the ratios provided by the organizations of different countries amyotrophic lateral sclerosis, idiopathic thrombocytopenic purpura and other congenital coagulation disorders etc. could be considered to be rare disorders. Number of compounds that are undergoing discovery and development for treatment of orphan disease has increased significantly in recent years, but numbers of orphan drugs approved in last 25 years are still only a drop in bucket compared with many thousands of orphan diseases. Understanding of the human genome, nuclear cloning, rational drug designing and application of high throughput screening in drug discovery programs, might lead to new drug discoveries for orphan diseases. Hence, there is hope in future for patients neglected by for-profit drug discovery efforts. The present review covers the concept of orphan drugs, need for its regulation, incentives achieved after orphan status, global market of orphan drugs, and various strategies of pharma companies regarding orphan drugs along with introduction to some orphan diseases.
Bookmarks Related papers MentionsView impact
Journal of Diabetes and its Complications, 2011
Erectile dysfunction (ED) is defined as the inability of the male to attain and maintain erection... more Erectile dysfunction (ED) is defined as the inability of the male to attain and maintain erection of penis sufficient to permit satisfactory sexual intercourse. Prevalence of impotence in diabetic men is ≥50%. The pathophysiology of diabetes-induced erectile dysfunction (DIED) is multifactorial and no single etiology is at the forefront. The proposed mechanisms of erectile dysfunction in diabetic patients includes elevated advanced glycation end-products, increased levels of oxygen free radicals, impaired nitric oxide synthesis, increased endothelin B receptor binding sites and up-regulated RhoA/Rho-kinase pathway, neuropathic damage and impaired cyclic guanosine monophosphate (cGMP)-dependent protein kinase-1. The treatment of DIED is multimodal. Treatment of the underlying hyperglycemia and comorbidities is of utmost importance to prevent or halt the progression of disease. Oral medications are considered as the first line therapy for management of DIED. If oral agents cannot be used or have insufficient efficacy despite appropriate dosing and education, second-line treatments should be addressed. When there is lack of efficacy or when there is dissatisfaction with other modalities, penile prostheses are often the best alternative for ED and are considered as the third line therapy for DIED. Future strategies in the evolution of the treatment of DIED are aimed at correcting or treating the underlying mechanisms of DIED.
Bookmarks Related papers MentionsView impact
Uploads
Papers by Ajay Kshirsagar